You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
2022年醫藥:保持樂觀,在創新和產業鏈升級中尋找新機遇

本文來自格隆匯專欄:開源證券研究所,作者:蔡明子 餘汝意

展望2022年,開源證券醫藥團隊核心觀點為:

1、未來創新和產業升級仍是主題,看好具有源頭創新能力和差異化競爭力的企業逐步進入全球市場,參與全球競爭,開拓成長空間;產業鏈升級、供給側深化改革持續推進,行業集中度將加速提升,落後的生產方式及欠合規的經營模式將加速淘汰,行業將回歸以創新為驅動、以患者為中心的本源。看好能把握行業發展趨勢,始終以臨牀需求為中心、以創新驅動高質量發展的優質標的的投資機會。

2、展望2022年,建議重點關注估值修復到位、經營有拐點、業績確定性高的個股機會,板塊上依然看好醫藥外包服務、連鎖龍頭(服務、藥店、醫美等機構)、生物醫藥上游、創新醫療器械、特色原料藥、品牌中藥等領域 。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account